DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 72 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 248.60 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,195,000 | -75.9% | 125,000 | -77.3% | 0.11% | -74.7% |
| Q4 2017 | $4,967,000 | +13.6% | 550,000 | -27.7% | 0.42% | -8.7% |
| Q3 2017 | $4,371,000 | +72.4% | 760,233 | -5.0% | 0.46% | +22.7% |
| Q2 2017 | $2,536,000 | -6.8% | 800,000 | 0.0% | 0.37% | -11.6% |
| Q1 2017 | $2,720,000 | +31.3% | 800,000 | +11.2% | 0.42% | +185.8% |
| Q4 2016 | $2,072,000 | +0.7% | 719,450 | +105.6% | 0.15% | -32.4% |
| Q3 2016 | $2,058,000 | – | 350,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |